Cara Therapeutics | Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Alterity Therapeutics Limited AUD 7.78M 3M 2023-06
Assertio Holdings USD 105.8M 12.5M 2025-09
Cara Therapeutics USD 4.96M 2.38M 2025-03
Cassava Sciences USD 11.86M 2.23M 2025-09
Chugai Pharma JPY 177.3B 604M 2025-12
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 9.78M 90K 2025-09
CSL USD 2.87B 2.85B 2025-06
Grifols EUR 1.77B 22.04M 2025-09
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
J&J USD 18.97B 2.38B 2025-12
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Pacira USD 166.36M 4.5M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
RedHill Biopharma USD 5.51M 1.08M 2024-06
Supernus Pharmaceuticals USD 252.29M 98.98M 2025-09
Vanda Pharmaceuticals USD 466M 20.33M 2025-09


Cara Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.